IBEX Limited IBEX Warrants and Rights Outstanding

Warrants and Rights Outstanding at other companies

Nuvation BioNUVB

5.8M0.0%

KEE

Keel Infrastructure Corp. Common StockKEEL

2.2M—

Unusual MachinesUMAC

0-100%

KRAKacquisition KRAQ

0—

The RealRealREAL

7.9M—

NuScale PowerSMR

0-100%

Other financials

Income statement

See full

Revenue$164.4M+16.8%

Gross profit$48.8M+9.1%

Operating income$16.2M+21.2%

Net income$13.3M+27.3%

EPS (diluted)$0.89+21.9%

Balance sheet

See full

Cash & equivalents$15.4M+18.7%

Total debt$63.2M-44.1%

Total equity$160.8M+29.5%

Total assets$297.2M+8.2%

Cash flow

See full

Operating cash flow$11.9M+34.4%

CapEx$5.3M+0.1%

Free cash flow$6.6M+85.1%

Valuation

See full

Market cap$389.76M+6.1%

Enterprise value$437.58M-6.4%

P/E8.3×-1.6×

P/S0.6×-0.1×

Profitability

See full

Gross margin29.9%-1.0pp

Operating margin9.2%+0.3pp

Net margin7.5%+0.6pp

FCF margin5.3%+2.8pp

Returns & leverage

See full

Return on equity33.1%+6.9pp

Debt / equity0.4×-0.5×

Current ratio2×+0.3×

Where this comes from

Reported directly by IBEX Limited in its filing.

Tagged under the XBRL concept us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.

The official record: IBEX Limited’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →